Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology

Current Medical Research and Opinion

Volumn 19, Issue 2, 2003, Pages 83-88

  Baer, G ^a,b   Loumaye, E ^b  

^a Laboratoires Serono   (Switzerland)

^b Serono International SA   (Switzerland)

Author keywords

Assisted reproductive technology; Folliculogenesis; Luteinising hormone; Ovulation induction; Recombinant drugs

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

CLINICAL TRIAL; ENDOMETRIUM; ESTROGEN RELEASE; FEMALE; HORMONE ACTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INFERTILITY THERAPY; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVULATION; OVULATION INDUCTION; SHORT SURVEY; SPONTANEOUS ABORTION; THICKNESS;

EID: 0037622071     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/0300799039117032     Document Type: Short Survey

References (35)

1. Hsueh AJ, Adashi EY, Jones PB, Welsh TH Jr. Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocr Rev 1984;5:76-127
2. Zeleznik AJ, Hillier SC. The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol 1984;27:927-40
3. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-91
4. Falck. Site of the production of estrogen in rat ovary as studies in micro-transplants. Thesis, University of Lund, 1959
5. Eshkol A, Lunenfeld B. Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human menopausal gonadotrophin (HMG). 3. Effects of a biologically apparently pure FSH preparation on ovaries and uteri of intact immature mice. Acta Endocrinol (Copenh) 1967;54:91-5
6. Mannaerts B, de Leeuw R, Geelen J, Van Ravestein A, Van Wezenbeek P, Schuurs A. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology 1991;129:2623-30
7. Berger MJ, Taymor ML. The role of luteinizing hormone in human follicular maturation and function. Am J Obstet Gynecol 1971;111:708-10
8. Shoham Z, Mannaerts B, Insler V, Coelingh-Bennink H. Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil Steril 1993;59:738-42
9. Filicori M, Cognigni GE, Taraborrelli S, et al. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999;84:2659-63
10. Stokman PG, de Leeuw R, van den Wijngaard HA, Kloosterboer HJ, Verner HM, Sanders AL. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril 1993;60:175-8
11. Guidice E, Crisci C, Altarocca V, O'Brien M. Characterisation of a partially purified human menopausal gonadotropin preparation. J Clin Res 2001;4:27-33
12. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998;83:1507-14
13. Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002;77:1170-7
14. Hillier SG. Ovarian stimulation with recombinant gonadotrophin: LH as an adjunct to FSH. In: Jacobs HS, ed. The New Frontier in Ovulation Induction. Carnforth, UK: Parthenon, 1993:39-47
15. Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385-93
16. Howles CM, Macnamee MC, Edwards RG, Goswamy R, Steptoe PC. Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet 1986;2:521-2
17. Shoham Z, Borenstein R, Lunenfeld B, Pariente C. Hormonal profiles following clomiphene citrate therapy in conception and non-conception cycles. Clin Endocrinol (Oxf) 1990;33:271-8
18. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;297:1024-6
19. Sagle M, Bishop K, Ridley N, et al. Recurrent early miscarriage and polycystic ovaries. BMJ 1988;297:1027-8
20. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990;336:1141-4
21. Levy DP, Navarro JM, Schattman GL, Davis OK, Rosenwaks Z. The role of LH in ovarian stimulation: exogenous LH: let's design the future. Hum Reprod 2000;15:2258-65
22. Chappel S, Kelton C, Nugent N. Basic knowledge about recombinant gonadotropic hormone production. In: Shoham Z, Howles CM, Jacobs HS, eds. Female Infertility Therapy, Current Practice. London: Martin Dunitz, 1999:95-102
23. Naylor SL, Chin WW, Goodman HM, Lalley PA, Grzeschik KH, Sakaguchi AY. Chromosome assignment of genes encoding the alpha and beta subunits of glycoprotein hormones in man and mouse. Somatic Cell Genet 1983;9:757-70
24. Bogdanove EM, Gay VL. Studies on the disappearance of LH and FSH in the rat; a quantitative approach to adenohypophysial secretory kinetics. Endocrinology 1969;84:1118-31
25. Porchet HC, Le Cotonnec J-Y, Neuteboom B, Canali S, Zanolo G. Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. J Clin Endocrinol Metab 1995;80:667-73
26. Shoham Z, Homburg R, Jacobs HS. Induction of ovulation with pulsatile GnRH. Baillieres Clin Obstet Gynaecol 1990;4:589-608
27. Channing CP, Kammerman S. Binding of gonadotropins to ovarian cells. Biol Reprod 1974;10:179-98
28. Shoham Z, Jacobs HS, Insler V. Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 1993;59:1153-61
29. Rodgers M, Mitchell R, Lambert A, Peers N, Robertson WR. Human chorionic gonadotrophin contributes to the bioactivity of Pergonal. Clin Endocrinol (Oxf) 1992;37:558-64
30. Van Hell H, Matthijsen R, Overbeek GA. Effects of human menopausal gonadotrophin preparation in different bioassay methods. Acta Endocrinol 1964;47:409-18
31. Westergaard LG, Erb K, Laursen SB, Rex S, Rasmussen PE. Human menopausal gonadotropin versus recombinant folliclestimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril 2001 Sep;76(3):543-9
32. Fanchin R, Hourvitz A, Olivennes F, Taieb J, Hazout A, Frydman R. Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture. Fertil Steril 1997;68:648-52
33. Luveris® Product Monograph. Geneva: Serono (undated)
34. le Cotonnec J-Y, Porchet HC, Beltrami V, Munafo A. Clinical pharmacology of recombinant human luteinizing hormone. Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertil Steril 1998;69:189-94
35. Burgues S. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod 2001;16:2525-32